Exo-Harvest Platform Operational
EXO-Harvest launches scalable bioreactor platform for efficient MSC and EV production, developed in collaboration with IPRATECH.
We are thrilled to announce the successful launch of our cutting-edge multi-scale bioreactor platform for adherent cells and extracellular vesicles (EVs) production, in partnership with IPRATECH.
The platform is now fully operational, marking a significant milestone in joint efforts to advance biotechnological solutions through engineering excellence. EXO-Harvest’s launch of the breakthrough multi-scale bioreactor platform will help overcome the challenges of MSC and EV manufacturing, to make therapies triple A from day one —available, accessible, and affordable. This innovative technology has been integrated by convEyXO into its anti inflamm-aging platform to successfully industrialize EVs manufacturing.
𝐀𝐛𝐨𝐮𝐭 𝐈𝐏𝐑𝐀𝐓𝐄𝐂𝐇
IPRATECH is dedicated to advancing biotechnological solutions through engineering excellence. Thanks to IPRATECH's collaboration, we have successfully integrated the fixed bed in the manufacturing process, turning our vision into reality.
Become a partner
Reach out to learn more.